THOMAS HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.2M
- Transactions
- 326
- Companies
- 18
- Average per transaction
- $3,738
Who reported the payments
| Merck | $540,505 |
| Genentech, Inc. | $322,908 |
| Amgen | $121,597 |
| AstraZeneca | $54,192 |
| Eli Lilly | $50,153 |
| Biotronik Inc. | $36,878 |
| Novocure GmbH | $20,900 |
| Boston Scientific | $18,516 |
| AbbVie | $18,403 |
| Pfizer | $17,083 |
| Medtronic | $11,354 |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,500 |
| Boehringer Ingelheim | $1,650 |
| Organon | $700 |
| Novocure Inc. | $500 |
| Medline Industries LP | $414 |
| Baxter Healthcare | $205 |
| Zimmer Biomet | $32 |